Bryce Point Capital LLC acquired a new stake in Genpact Limited (NYSE:G - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 11,356 shares of the business services provider's stock, valued at approximately $488,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. boosted its position in Genpact by 0.4% during the 4th quarter. Vanguard Group Inc. now owns 16,962,496 shares of the business services provider's stock valued at $728,539,000 after buying an additional 61,376 shares during the period. Victory Capital Management Inc. boosted its holdings in shares of Genpact by 18.1% during the fourth quarter. Victory Capital Management Inc. now owns 9,853,437 shares of the business services provider's stock worth $423,205,000 after purchasing an additional 1,511,790 shares during the period. Franklin Resources Inc. grew its stake in shares of Genpact by 1.3% in the fourth quarter. Franklin Resources Inc. now owns 4,203,956 shares of the business services provider's stock worth $180,560,000 after purchasing an additional 55,771 shares during the last quarter. Geode Capital Management LLC increased its holdings in Genpact by 3.6% during the 4th quarter. Geode Capital Management LLC now owns 3,825,344 shares of the business services provider's stock valued at $170,175,000 after purchasing an additional 133,938 shares during the period. Finally, JPMorgan Chase & Co. raised its position in Genpact by 8.7% during the 4th quarter. JPMorgan Chase & Co. now owns 3,400,636 shares of the business services provider's stock valued at $146,057,000 after purchasing an additional 271,295 shares during the last quarter. Institutional investors own 96.03% of the company's stock.
Wall Street Analysts Forecast Growth
Several equities analysts have recently issued reports on the company. Needham & Company LLC boosted their target price on Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a research note on Friday, February 7th. Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and boosted their price objective for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Mizuho raised their target price on shares of Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a research report on Monday, February 10th. Finally, TD Cowen upgraded shares of Genpact from a "hold" rating to a "buy" rating and boosted their price target for the company from $45.00 to $60.00 in a research report on Friday, February 7th. Six research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $48.44.
Check Out Our Latest Analysis on G
Insider Activity
In related news, SVP Piyush Mehta sold 12,000 shares of the firm's stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the sale, the senior vice president now owns 151,182 shares in the company, valued at approximately $6,475,125.06. This trade represents a 7.35 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Balkrishan Kalra sold 13,600 shares of the business's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the sale, the chief executive officer now owns 310,246 shares of the company's stock, valued at approximately $15,167,926.94. This represents a 4.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 2.80% of the company's stock.
Genpact Stock Down 4.3 %
Shares of G traded down $2.08 during trading hours on Thursday, hitting $46.04. The company had a trading volume of 270,163 shares, compared to its average volume of 1,350,543. The stock has a market capitalization of $8.09 billion, a price-to-earnings ratio of 16.18, a P/E/G ratio of 1.84 and a beta of 1.06. The firm has a fifty day moving average price of $51.09 and a 200-day moving average price of $45.67. Genpact Limited has a 52-week low of $30.23 and a 52-week high of $56.76. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16.
Genpact (NYSE:G - Get Free Report) last issued its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. On average, equities research analysts forecast that Genpact Limited will post 3.21 EPS for the current fiscal year.
Genpact Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th were paid a $0.17 dividend. The ex-dividend date of this dividend was Tuesday, March 11th. This represents a $0.68 annualized dividend and a dividend yield of 1.48%. This is a boost from Genpact's previous quarterly dividend of $0.15. Genpact's payout ratio is currently 23.94%.
Genpact Company Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report